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Abstract—One important application of nanotechnology is that of
drug delivery, and in particular the targeted delivery of drugs
using nanotubes. A proper understanding of the encapsulation
behavior of drug molecules into nanotubes is vital for the
development of nanoscale drug delivery vehicles. Furthermore,
there are many other materials which may form single-walled
nanotubes, such as carbon, boron carbide, boron nitride and
silicon, and it is also important to understand their advantages
and disadvantages. This paper presents a synopsis of the recent
work in which boron nitride, boron carbide and silicon
nanotubes are examined as drug delivery vehicles, and their
encapsulation behavior is compared to previous work of the
authors on carbon nanotubes.
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INTRODUCTION

The idealized ‘magic bullet’ concept [1], first proposed at
the beginning of the 20th century is now becoming a reality
due to the advent of nanotechnology, and in particular the use
of nanoparticles and nanotubes as delivery vehicles. In
principle, an ideal drug carrier is injected into the body and
transports itself to the correct target, such as a tumor, and
delivers the required dose at this target. Due to their precise
targeting nature and their protective environment, these
nanoscale drug carriers enable a stronger drug to be used at a
lower dose, resulting in fewer of the adverse side effects which
exist for current methods, such as the highly toxic
chemotherapeutic cancer treatments. Also, nanocapsules offer
improvements to drug delivery methods for infections,
metabolic diseases, autoimmune diseases, and pain treatment
as well as for gene therapy [1].

Figure 1. Outline of the proposed drug delivery process. (a) Nanotube
surface is functionalized with a chemical receptor and the drug molecules are
encapsulated, (b) open end is capped, (c) nanocapsule is ingested and locates
to target site due to functionalized surface, (d) cell internalizes the capsule for
example by receptor mediated endocytosis, (c) cap is removed or biodegrades
inside cell, and (f) drug molecules are released [7].

to enter cell nuclei [5] suggesting another advantage in that
they may be useful in gene therapy. The general proposed drug
delivery process using nanotubes, in this case in the form of
nano test tubes [6], is illustrated in Fig. 1.
Ultimately, we want to design a nanotube carrier such that
prior to delivery it is energetically favorable for the drug
molecule to be encapsulated, and once inside the desired cell it
is energetically favorable to be ejected. Thus, the contents are
deposited to the target site. Understanding the encapsulation
and expulsion of drug molecules from nanocarriers is vital for
the development of nanoscale drug delivery. As stated by
Ferrari [8] “Novel mathematical models are needed, in order to
secure the full import of nanotechnology into oncology.”

To date, nanoparticles have been used for drug delivery and
cosmetics and it has only been recently that nanotubes have
gained significant attention. Nanotubes offer a number of
advantages which suggest that they may provide an improved
result [2]. Namely, they have a larger inner volume which
allows more drug molecules to be encapsulated, and they have
distinct inner and outer surfaces for functionalization. In
addition, the volume and surfaces of the nanotube are more
readily accessible since the end caps can be easily removed.
Both nanoparticles and nanotubes have been shown to be
readily taken up by cells [3, 4], and nanotubes have been found

Motivated by recent research into the suction of fullerenes
into carbon nanotubes [9], we investigate the encapsulation
behavior of a particular anticancer drug molecule entering a
nanotube using applied mathematical modeling techniques and
elementary mechanics. In particular, we determine the
minimum radius of nanotube that will accept the anticancer
drug cisplatin into its interior, and we determine the tube radius
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that provides the maximum drug uptake. Cisplatin is a platinum
based anticancer drug which is used to treat a wide range of
tumors, despite its adverse side effects. It is expected that this
form of targeted nanoscale drug delivery will significantly
reduce these adverse side effects.

continuously, thereby enabling irregular shaped molecules,
such as drugs, to be represented whilst maintaining the time
saving advantage of the continuous approach. Using the hybrid
discrete-continuous approach [21], the interaction energy is
given by

Single-walled nanotubes may be formed from a range of
materials, such as carbon, boron nitride, boron carbide and
silicon [10], and the list of possible materials is constantly
growing [11]. Since their discovery, carbon nanotubes have
generated considerable research and development for
nanomechanical devices due to their demonstrated remarkable
and unique electrical, mechanical, and optical properties.
Nanotubes formed from alternative materials may be more
biocompatible and be better for use in nanomedical devices,
and as such it is important to understand the various advantages
and disadvantages of these alternative materials. For example,
boron nitride nanotubes share many of the excellent properties
of carbon nanotubes because they share the same structure
[12]. However, compared to carbon nanotubes, boron nitride
nanotubes offer improved performance, through their high
chemical stability, and high resistance to oxidation at high
temperatures [13]. Furthermore, boron nitride tubes have
already shown improvement over carbon nanotubes in the area
of gigahertz oscillators [14, 15], in which boron nitride based
oscillators generate higher oscillatory frequencies. Due to their
biocompatibility [16, 17] boron nitride nanotubes may be
particularly suitable for nanomedical applications. Similarly,
silicon, with proven biocompatibility [18], has been widely
used in the development of biomedical devices, such as neural
prostheses and biochips, and therefore may also be a good
material for nanomedical devices.

E = ∑ η ∫ υ (ρ i )dS ,

where η is the mean surface density of atoms on the
continuously modeled molecule, υ(ρi) is the potential function,
and ρi is the distance between atom i on the discretely modeled
molecule and a typical surface element dS on the continuously
modeled molecule. The hybrid model has been shown to
compare well to the typically used, discrete atom-atom and
continuous, methods [21]. Note that the various components of
the interaction force are determined by the negative gradient of
the interaction energy (1). In particular, due to symmetry, of
specific interest is the axial force, which is given by F =
−dE/dZ and illustrated in Fig. 2.
In this paper the potential function υ(ρi) is described by the
Lennard-Jones potential which applies to non-bonded, nonpolar atomic interactions, and is given by

υ (ρ ) = − Aρ −6 + Bρ −12 ,

(2)

where A and B are the attractive and repulsive constants,
respectively. In some cases, such as in this investigation, the
force constants for the interaction between two atoms is
unavailable, and the empirical combining rules [20, 22] may be
used to determine approximate constants. Typically, a solvent
medium is used to deliver drug molecules, and although this is
not specifically addressed in this paper it may be incorporated
by adjusting the Lennard-Jones constants by a factor of the
dielectric constant of the solvent [20, 22].

This paper provides a synopsis of recent work by the
authors [19], in which the encapsulation behaviors of the
anticancer drug cisplatin entering a boron nitride, boron carbide
and silicon nanotube are compared to earlier work investigating
the encapsulation of cisplatin into carbon nanotubes [20]. Our
aim is to determine if there is an improved encapsulation
behavior for the alternative nanotube materials. The technique
presented here may be applied to any particular drug molecule,
provided that the atom coordinates are known. However, the
drug cisplatin is chosen in the interest of drawing a direct
comparison to our earlier work [20]. We comment that this
paper draws on a mathematical formulation proposed in an
earlier paper by the authors [21].
II.

(1)

i

To understand the encapsulation behavior of a particular
drug molecule as it enters a nanotube the concepts of an
acceptance condition and the suction energy [23] are used.
With reference to Fig. 2, a particular molecule (located at
negative Z and with no initial velocity) will be accepted into
the nanotube interior (positive Z) by van der Waals forces
alone provided that the work done or acceptance energy Wa
from –∞ to Z0 (the positive root of the interaction force, as
shown in Fig. 2) is positive. Fig. 3 illustrates the typical
behavior of the acceptance energy against nanotube radius a,
noting that the point where the curve crosses the x-axis, labeled
a0, is the minimum radius of nanotube that will accept a
particular molecule by van der Waals forces alone.

METHOD

A. Interaction energy, acceptance and suction
The intermolecular forces between two interacting
molecules is typically evaluated using either the discrete atomatom approach or by the continuum approach whereby the
atoms are assumed to be uniformly distributed over the surface
of each molecule. These approaches have their disadvantages,
the discrete atom-atom formulation can be time consuming
especially for large molecules, and the continuum approach is
mostly applicable to highly symmetric structures. This paper
utilizes the hybrid discrete-continuous approach [21] in which
one molecule is represented discretely and the other

Similarly, the suction energy W is the work done generated
by van der Waals interactions acquired by a particular
molecule as a consequence of being sucked into the nanotube
interior. Fig. 4 illustrates a typical suction energy, which
crosses the x-axis at amin and has a maximum at a nanotube
radius amax. Note that when the nanotube radius is equal to amin
it is energetically favorable for the molecule to be inside the
nanotube. However, when the radius is in the range amin < a <
a0, an additional energy is required for the molecule to be
encapsulated. For further details the reader is referred to Hilder
and Hill [20].
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B. Nanotube materials
A carbon nanotube can be thought of as a sheet of graphite
rolled up into a seamless hollow cylinder. Similarly, boron
nitride, boron carbide and silicon can all form graphite-like
nanotubes [11, 12, 24-31]. However, silicon nanowires have
been observed much more readily [32] due to the preference of
sp3 bonding [33], despite this, silicon nanotubes have been
reported experimentally [30, 31]. By use of the empirical
combining rules [20, 22], the Lennard-Jones constants are
determined and are summarized in Table I [19, 20]. For further
details of the method used we refer the reader to [19-21].
TABLE I.

LENNARD-JONES CONSTANTS
A (eV×
×Å6)

Atom

Figure 2. Typical interaction force between a drug molecule and a nanotube.
Note that negative Z is outside the nanotube and positive Z is inside.

B (eV×
×Å12)

Boron-boron

27.91

47304

Nitrogen-nitrogen

36.48

52955

Carbon-carbon

19.96

34792

Silicon-silicon

436.91

2742630

Chlorine-chlorine

612.76

3445961

Hydrogen-hydrogen

10.51

5363

Platinum-platinum

287.85

1044434

III.

RESULTS AND DISCUSSION

Following Hilder and Hill [20], three orientations of
cisplatin are examined. Table II outlines approximate values
for the nanotube radii which provide acceptance a0, maximum
suction amax, and the energetically favorable radius amin. More
specifically, to accept all three orientations of cisplatin the
nanotube must have a radius of at least 4.895 Å, 4.875 Å, 4.894
Å and 5.226 Å for carbon (CNT), boron nitride (BNNT), boron
carbide (BCNT) and silicon (SiNT) nanotubes, respectively
[19]. The boron nitride nanotube has the smallest radius for
acceptance, and thus the smallest radius to be efficiently filled
with cisplatin. Accordingly, the boron nitride nanotube requires
the least amount of material to deliver the drug, and as a result
provides the least toxicity. Once the drug is ejected inside the
cell the remaining nanocapsule may either slowly clear from
the body or may remain, thus it is vital to reduce the amount of
material required for efficient encapsulation. Alternatively, a
silicon nanotube requires the largest radius for acceptance.

Figure 3. Typical acceptance energy for a drug molecule entering a nanotube
of radius a, with the minimum radius of acceptance a0 indicated.

Comparing the magnitude of the suction energy at the
maximum suction location illustrates a notable difference
between all four materials, and the order from the lowest to the
highest magnitude is boron carbide, boron nitride, carbon and
silicon. In particular, the magnitude for the silicon nanotube is
significantly larger than the other three materials. For
encapsulation this is a positive result, since a larger suction
energy results in a more efficient encapsulation. However,
upon expulsion there will be a higher energy barrier for the
encapsulated molecule to overcome. Therefore, the smaller
suction energies are preferable as they provide efficient
encapsulation in addition to minimizing the barrier upon
expulsion.

Figure 4. Typical suction energy for a drug molecule entering a nanotube of
radius a, with the energetically favorable radius amin, and the maximum uptake
radius amax indicated.
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VALUE amin, ACCEPTANCE a0, AND MAXIMUM SUCTION amax

[10] P. Fortina, L. J. Kricka, S. Surrey and P. Grodzinski,
“Nanobiotechnology: the promise and reality of new approaches to
molecular recognition”, Trends in Biotech., vol. 23, pp. 168-173, 2005.
[11] O. Ponomarenko, M. Radny and P. Smith, “Small-radius clean and metal
doped boron carbide nanotubes”, Phys. Rev. B, vol. 74, pp. 125421,
2006.
[12] M. Ishigami, S. Aloni and A. Zettl, “Properties of boron nitride
nanotubes”, AIP Conference Proceedings, vol. 696, pp. 94-99 [Scanning
Tunneling Microscopy/Spectroscopy and Related Techniques: 12th
International Conference STM’03].
[13] V. L. Solozhenko, A. G. Lazarenko, J. P. Petitet and A. V. Kanaev,
“Bandgap energy of graphite-like hexagonal boron nitride”, J. Phys.
Chem. Solids, vol. 62, pp. 1331-1334, 2001.
[14] J. H. Lee, “A study on a boron-nitride nanotube as a gigahertz
oscillator”, J. Korean Phys. Soc., vol. 49, pp. 172-176, 2006.
[15] N. Thamwattana and J. M. Hill, “Continuum modelling for carbon and
boron nitride nanostructures”, J. Phys.: Condens. Matter, vol. 19, pp.
406209, 2007.
[16] I. Dion et al., “Physico-chemistry and cytotoxicity of ceramics. Part II
Cytotoxicity of ceramics”, J. Mater. Sci.: Mater. Med., vol. 5, pp. 18-24,
1994.
[17] C. Zhi, Y. Bando, C. Tang and D. Golberg, “Immobilization of proteins
on boron nitride nanotubes”, J. Am. Chem. Soc., vol. 127, pp. 1714417145, 2005.
[18] C. Mu, Q. Zhao, D. Xu, Q. Zhuang and Y. Shao, “Silicon nanotube
array/gold electrode for direct electrochemistry of cytochrome c”, J.
Phys. Chem. B, vol. 111, pp. 1491-1495, 2007.
[19] T. A. Hilder and J. M. Hill, “Theoretical comparison of nanotube
materials for drug delivery”, Micro Nano Lett., vol. 3, pp. 18-24, 2008.
[20] T. A. Hilder and J. M. Hill, “Modelling the encapsulation of the
anticancer drug cisplatin into carbon nanotubes”, Nanotech., vol. 18, pp.
275704, 2007.
[21] T. A. Hilder and J. M. Hill, “Continuous versus discrete for interacting
carbon nanostructures”, J. Phys. A: Math. Theor., vol. 40, pp. 38513868, 2007.
[22] M. Rigby, E. B. Smith, W. A. Wakeham and G. C. Maitland, The forces
between molecules. Oxford: Oxford University Press, 1986.
[23] B. J. Cox, N. Thamwattana and J. M. Hill, , “Mechanics of atoms and
fullerenes in single-walled carbon nanotubes. I. Acceptance and suction
energies”, Proc. R. Soc. A, vol. 463, pp. 461-476, 2007.
[24] P. Widmayer, H. G. Boyen, P. Ziemann, P. Reinke and P. Oelhafen,
“Electron spectroscopy on boron nitride thin films: Comparison of nearsurface to buk electronic properties”, Phys. Rev. B, vol. 59, pp. 52335241, 1999.
[25] J. Kouvetakis, R. B. Kaner, M. L. Sattler and N. Bertlett, “A novel
graphite-like material of composition BC3, and nitrogen-carbon
graphites”, J. Chem. Soc., Chem. Commun., pp. 1758-1759, 1986.
[26] Y. Miyamoto, A. Rubio, S. G. Louie and M. L. Cohen, “Electronic
properties of tubule forms of hexagonal BC3”, Phys. Rev. B, vol. 50, pp.
18360-18366, 1994.
[27] Z. Weng-Sieh et al., “Synthesis of BxCyNz nanotubules”, Phys. Rev. B,
vol. 51, pp. 11229-11232, 1995.
[28] A. S. Barnard and S. P. Russo, “Structure and energetics of singlewalled armchair and zigzag silicon nanotubes”, J. Phys. Chem. B, vol.
107, pp. 7577-7581, 2003.
[29] S. B. Fagan, R. J. Baierle, R. Mota, A. J. R. da Silva and A. Fazzio, “Ab
initio calculations for a hypothetical material: Silicon nanotubes”, Phys.
Rev. B, vol. 61, 9994-9996, 2000.
[30] J. Sha et al., “Silicon nanotubes”, Adv. Mater., vol. 14, pp. 1219-1221,
2002.
[31] M. De Crescenzi et al., “Experimental imaging of silicon nanotubes”,
Appl. Phys. Lett., vol. 86, pp. 231901, 2005.
[32] R. Q. Zhang, S. T. Lee, C. –K. Law, W. –K. Li and B. K. Teo, “Silicon
nanotubes: why not?”, Chem. Phys. Lett., vol. 364, pp. 251-258, 2002.
[33] J. Bai, X .C. Zeng, H. Tanaka and J. Zeng, “Metallic single-walled
silicon nanotubes”, Proc. Natl. Acad. Sci., vol. 101, pp. 2664-2668, 2004

Orientation and corresponding radii (Å)
(i)

a

CNT

amin

a0

amax

amin

a0

amax

amin

a0

amax

4.76

4.80

5.34

4.76

4.90

5.34

4.74

4.79

5.27

4.76

4.77

5.3

4.76

4.88

5.3

4.71

4.75

5.23

b

4.78

4.79

5.34

4.78

4.89

5.34

4.74

4.78

5.27

5.12

5.13

5.73

5.12

5.23

5.73

5.08

5.13

5.67

BCNT
SiNT

(iii)

b

BNNT

b

(ii)

a. Hilder and Hill [20], b. Hilder and Hill [19]

IV.

CONCLUSIONS

In summary, the boron nitride nanotube provides the most
ideal delivery capsule in terms of minimizing the amount of
material required for encapsulation, thus providing the least
toxicity. This technique, used to represent the encapsulation of
cisplatin entering carbon, boron nitride, boron carbide and
silicon nanotubes, can be extended to any number of drug
molecules or alternative nanotube materials. It may be used to
provide overall guidelines to assist in future experimental and
molecular dynamics studies. It is hoped that in future work the
expulsion of the drug molecule, once the nanocapsule is inside
the cell, may be investigated. However, the expulsion occurs
in an extremely complicated environment and presents
challenges in terms of how best to model this environment.
ACKNOWLEDGMENT
The authors would like to thank their colleagues Dr Barry
Cox, Dr Ngamta Thamwattana and Duangkamon Baowan for
many helpful comments.
REFERENCES
[1]
[2]
[3]
[4]

[5]

[6]
[7]
[8]
[9]

P. Couvreur and C. Vauthier, “Nanotechnology: Intelligent design to
treat complex disease”, Pharm. Res., vol. 23, pp. 1417-1450, 2006.
C. R. Martin and P. Kohli, “Emerging field of nanotube biotechnology”,
Nature Rev.: Drug Discov., vol. 2, pp. 29-37, 2003.
D. A. LaVan, T. McGuire and R. Langer, “Small-scale systems for in
vivo drug delivery”, Nature Biotech., vol. 21, pp. 1184-1191, 2003.
N. W. S. Kam, T. C. Jessop, P. A. Wender and H. Dai, “Nanotube
molecular transporters: internalization of carbon nanotube-protein
conjugates into mammalian cells”, J. Am. Chem. Soc., vol. 126, pp.
6850-6851, 2004.
D. Pantarotto, J.-P. Briand, M. Prato and A. Bianco, “Translocation of
bioactive peptides across cell membranes by carbon nanotubes”, Chem.
Commun., vol. 1, pp. 16-17, 2004.
H. Hillebrenner et al., “Corking nano test tubes by chemical self
assembly”, J. Am. Chem. Soc., vol. 128, pp. 4236-4237, 2006.
T. A. Hilder and J. M. Hill, “A review of targeted drug delivery using
nanotubes”, unpublished.
M. Ferrari, “Cancer nanotechnology: Opportunities and challenges”,
Nature Rev.: Cancer, vol. 5, pp. 161-171, 2005.
B. J. Cox, N. Thamwattana and J. M. Hill, “Mechanics of atoms and
fullerenes in single-walled carbon nanotubes. II. Oscillatory behaviour”,
Proc. R. Soc. A, vol. 463, pp. 477-494, 2007.

112

